Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1<sup>+</sup> T-cell subsets.

Chu, Fuliang; Neelapu, Sattva S

Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1⁺ T-cell subsets.

Chu, Fuliang; Neelapu, Sattva S.

Afiliação

Chu F; Department of Lymphoma and Myeloma; The University of Texas M.D. Anderson Cancer Center; Houston, TX USA ; Center for Cancer Immunology Research; The University of Texas M.D. Anderson Cancer Center; Houston, TX USA.
Neelapu SS; Department of Lymphoma and Myeloma; The University of Texas M.D. Anderson Cancer Center; Houston, TX USA ; Center for Cancer Immunology Research; The University of Texas M.D. Anderson Cancer Center; Houston, TX USA.

Oncoimmunology ; 3(1): e28101, 2014 Jan 01.

Article em En | MEDLINE | ID: mdl-24808975

Palavras-chave

PD-1; T cell; clinical trial; lymphoma; rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google